Clinical Study

Endothelial Cell Loss after Phacoemulsification according to Different Anterior Chamber Depths

Table 3

Preoperative and postoperative logMAR CDVA.

ExamMean CDVA ± SD
ACD IACD IIACD III
NO2NO3NO4NO2NO3NO4NO2NO3NO4

Preoperatively0.53 ± 0.150.51 ± 0.120.56 ± 0.140.55 ± 0.170.49 ± 0.140.52 ± 0.090.51 ± 0.150.46 ± 0.100.52 ± 0.09
1 d postoperatively0.19 ± 0.070.18 ± 0.070.16 ± 0.070.21 ± 0.060.17 ± 0.070.18 ± 0.090.19 ± 0.060.17 ± 0.070.19 ± 0.07
1 mo postoperatively0.05 ± 0.050.07 ± 0.060.07 ± 0.080.05 ± 0.060.09 ± 0.050.07 ± 0.070.07 ± 0.060.04 ± 0.060.05 ± 0.06
2 mo postoperatively0.03 ± 0.050.05 ± 0.050.05 ± 0.060.05 ± 0.050.03 ± 0.050.06 ± 0.060.07 ± 0.060.03 ± 0.050.04 ± 0.06
value>0.05>0.05>0.05>0.05>0.05>0.05>0.05>0.05>0.05

CDVA = corrected distance visual acuity; NO = nuclear opalescence.
Comparison of three ACD groups in the same cataract nuclear opacity subgroups (Bonferroni and Dunnett’s T3 as post hoc analysis).